在急性氨酸中毒中体外排泄
Els A van der Wouden1, Angela Dekkers1, Hannah M E Kruis1
1Gelderse Vallei Hospital, Ede, 6716 RP, Netherlands.
BMJ case reports
|August 9, 2025
概括
严重的氨酸中毒可能危及生命. 这项案例研究突出显示了使用血液透析和持续毒性血液过 (CVVH-D) 治疗大量氨酸过量的成功治疗方法.
科学领域:
- 临床毒理学 临床毒理学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理动力学 药理动力学
背景情况:
- 严重的氨酸中毒会导致昏迷和死亡.
- 酸的药理动力学特性 (脏排泄率低,蛋白质结合率高) 通常使其抵抗体外排泄.
- 尽管有这些特性,但案例报告表明,体外方法可以有效.
研究的目的:
- 为了描述大规模的氨酸过量剂量的成功管理.
- 评估血液透析和持续毒性血液过 (CVVH-D) 在严重的氨酸中毒时的疗效.
- 审查现有的关于超量服用瓦尔酸盐的体外治疗方法的文献.
主要方法:
- 一名57岁的男性患者摄入了64克瓦尔酸盐.
- 最初的治疗包括6小时的血液透析.
- 血液透析后进行了18小时的连续毒性血液过 (CVVH-D),以防止反弹毒性.
主要成果:
- 患有大量氨酸过量剂量的患者已成功接受治疗.
- 血液透析有效地去除了氨酸,随后的CVVH-D阻止了毒性的复苏.
- 文献审查支持这些联合体外方法的好处.
结论:
- 血液透析是对严重的氨酸过量治疗的有益方法.
- 血液透析与持续毒性血液过 (CVVH-D) 的结合是严重的氨酸中毒的建议治疗策略.
- 身体外排泄可以有效,即使具有不利的药物动力学特征.
相关概念视频
Enhanced Elimination of Poison
581
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
581
Prevention of Further Absorption of Poison
925
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
925
Drug Elimination: Non-Renal Routes
2.5K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.5K
Hepatic Drug Excretion: Enterohepatic Cycling
1.8K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.8K
Drug Excretion: Miscellaneous Routes
128
Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific...
128
Drug Elimination by Renal Route: Tubular Reabsorption
3.9K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.9K


